Description: Imagion Biosystems Limited provides medical imaging technologies to detect and eliminate cancer. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company engages in the research and development of its MagSense system to detect HER2 breast cancers. It uses MagSense technology that is based on superparamagnetic relaxometry for early cancer detection, cancer staging, and therapeutic monitoring. The company was founded in 1996 and is based in San Diego, California.
Home Page: imagionbiosystems.com
Level 4
Melbourne,
VIC
3205
Australia
Phone:
61 3 9692 7222
Officers
| Name | Title |
|---|---|
| Mr. Robert Romeo Proulx | Executive Chairman |
| Mr. Ward Detwiler | Chief Business Officer |
| Ms. Melanie Leydin C.A. | Non-Executive Director & Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.4591 |
| Price-to-Sales TTM: | 0.2984 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |